In the News
Combined angiotensin inhibition increased risks of adverse events in diabetic nephropathy
Combination therapy with an angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker in patients with diabetic nephropathy was associated with an increased risk of adverse events, including hyperkalemia and acute kidney injury, a study found.
Marked HDL reductions may occur with fenofibrate plus thiazolidinedione
Patients with type 2 diabetes taking fenofibrate plus a thiazolidinedione may experience significant reductions in high-density lipoprotein (HDL) cholesterol, according to a recent study.
Mail order pharmacy patients with diabetes less likely to visit ED than brick-and-mortar pharmacy users
Patients with diabetes who used a mail order pharmacy were less likely to visit the ED than patients who obtained medication in person from a pharmacy, a study found.
MKSAP Quiz: Abdominal pain in a type 1 diabetic
This month's quiz asks readers to evaluate a 40-year-old woman in the emergency department for a 7-hour history of gradually worsening generalized abdominal pain, hyperventilation, and lethargy.
Geriatrics society updates guideline for older diabetes patients
Several changes to recommended care for diabetes patients over age 65, including less use of aspirin therapy, were made in a guideline update from the American Geriatrics Society.
Chelation may reduce mortality, cardiovascular events in diabetics after MI
Chelation reduced cardiovascular disease events in patients with diabetes who had a previous myocardial infarction (MI), a recent study found.
Advice on using oral therapy
When initiating oral therapy for patients in whom diet and exercise do not adequately control type 2 diabetes, consider some advice from ACP Smart Medicine and ACP DiabetesMonthly's physician editor.
Spotlight on diabetes medications and cancer risks
The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.